<- Go Home
Sigma-Aldrich Corporation
Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide. It offers products in the areas of analytical chemistry, cell culture and analysis, chemistry and biochemicals, clinical and diagnostics, filtration, industrial microbiology, labware, materials science, molecular biology and functional genomics, mRNA development and manufacturing, pharma and biopharma manufacturing, protein biology, and water purification. It offers media and critical raw materials for industrial cell culture, contract manufacturing services, pharmaceutical safety testing services, and organometallic precursors for semiconductor manufacturing. The company also manufactures meglumine, an amino sugar derived from glucose and a component of medical imaging contrast media. It sells its products to pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies, and hospitals. The company was founded in 1951 and is based in Burlington, Massachusetts with additional offices worldwide. Sigma-Aldrich Corporation operates as a subsidiary of Merck KGaA.
Market Cap
$16.8B
Volume
960.0K
Cash and Equivalents
$1.2B
EBITDA
$829.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.4B
Profit Margin
51.60%
52 Week High
$140.03
52 Week Low
$135.33
Dividend
N/A
Price / Book Value
4.99
Price / Earnings
34.18
Price / Tangible Book Value
7.19
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$698.0M
Return on Equity
15.26%
Return on Assets
10.36
Cash and Short Term Investments
$1.2B
Debt
$300.0M
Equity
$3.4B
Revenue
$2.8B
Unlevered FCF
$514.3M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium